CoChat

The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.

Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice

Open access

Abstract

Technological advancements have enabled the extended investigation, development, and application of computational approaches in various domains, including health care. A burgeoning number of diagnostic, predictive, prognostic, and monitoring biomarkers are continuously being explored to improve clinical decision making in neuro-oncology. These advancements describe the increasing incorporation of artificial intelligence (AI) algorithms, including the use of radiomics. However, the broad applicability and clinical translation of AI are restricted by concerns about generalisability, reproducibility, scalability, and validation. This Policy Review intends to serve as the leading resource of recommendations for the standardisation and good clinical practice of AI approaches in health care, particularly in neuro-oncology. To this end, we investigate the repeatability, reproducibility, and stability of AI in response assessment in neuro-oncology in studies on factors affecting such computational approaches, and in publicly available open-source data and computational software tools facilitating these goals. The pathway for standardisation and validation of these approaches is discussed with the view of trustworthy AI enabling the next generation of clinical trials. We conclude with an outlook on the future of AI-enabled neuro-oncology.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(24)00315-2

Cites

120 of 120 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 120 references

Research works printed but not linked: 1

  1. Baheti, 2021, The Brain Tumor Sequence Registration Challenge (BraTS-Reg): Establishing Correspondence between Pre-Operative and Follow-up MRI scans of diffuse glioma patients, arXiv

Cited by

See all 40

Metadata

Authors
Bakas, S., Vollmuth, P., Galldiks, N., Booth, T. C., Aerts, H. J. W. L., Bi, W. L., Wiestler, B., Tiwari, P., Pati, S., Baid, U., Calabrese, E., Lohmann, P., Nowosielski, M., Jain, R., Colen, R., Ismail, M., Rasool, G., Lupo, J. M., Akbari, H., Tonn, J. C., Macdonald, D., Vogelbaum, M., Chang, S. M., Davatzikos, C., Villanueva-Meyer, J. E., & Huang, R. Y.
Affiliations
  • Indiana University Indianapolis (US)
  • University of Bonn (DE)
  • Forschungszentrum Jülich (DE)
  • King's College London (GB)
  • Brigham and Women's Hospital (US)
  • Technical University of Munich (DE)
  • University of Wisconsin–Madison (US)
  • Duke University (US)
  • Universitätsklinikum Aachen (DE)
  • Innsbruck Medical University (AT)
  • New York University (US)
  • University of Pittsburgh (US)
  • Moffitt Cancer Center (US)
  • University of California, San Francisco (US)
  • Santa Clara University (US)
  • Ludwig-Maximilians-Universität München (DE)
  • University of Pennsylvania (US)
Corresponding author
Bakas, Spyridon
Venue
The Lancet Oncology
Publisher
Elsevier BV
Published
2024-11
Volume
25
Issue
11
Pages
e589-e601
ISSN
1470-2045 (ISSN-L)
OpenAlex
W4403855186
Cited by
36
References
119
Citations by year
2026: 17 · 2025: 17 · 2024: 2
FWCI
0.82
Type
journal article
Language
en
Open access
Locations
  • The Lancet Oncology (acceptedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion)
  • PubMed Central (acceptedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion, other-oa)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
Funders
  • Musella Foundation For Brain Tumor Research and Information
  • Deutsche Forschungsgemeinschaft (428090865/SPP 2177)
  • University of Pennsylvania
  • European Research Council (866504)
  • U.S. Department of Defense
  • Perelman School of Medicine, University of Pennsylvania
  • U.S. Department of Veterans Affairs (1I01BX005842\u201301A2)
  • Wellcome Trust
  • Dana Foundation
  • National Institutes of Health
  • University of Wisconsin-Madison
  • Department of Radiology, Weill Cornell Medicine
  • NINDS (R01NS042645)
  • National Center for Advancing Translational Sciences (UL1TR001878)
  • Instituto Tecnológico de Costa Rica
  • European Commission
  • Medical Research Council (MR/W021684/1)
  • DOD Peer Reviewed Cancer Research Program (W81XWH-18\u20131-0404)
  • National Cancer Institute
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
Keywords
artificial intelligence, neuro-oncology, treatment response assessment, radiomics, AI validation, reproducibility, generalizability, trustworthy AI, clinical trials, good clinical practice, open source tools, clinical translation
MeSH terms
Artificial Intelligence, Brain Neoplasms, Humans, Medical Oncology, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice. https://app.cochat.ai/papers/10.1016/s1470-2045(24)00315-2
The paper
Bakas, S., Vollmuth, P., Galldiks, N., Booth, T. C., Aerts, H. J. W. L., Bi, W. L., Wiestler, B., Tiwari, P., Pati, S., Baid, U., Calabrese, E., Lohmann, P., Nowosielski, M., Jain, R., Colen, R., Ismail, M., Rasool, G., Lupo, J. M., Akbari, H., . . . Huang, R. Y. (2024). Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(24)00315-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.